LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $355,745 | +17.5% | 4,222 | +2.0% | 0.00% | – |
Q1 2024 | $302,749 | +4.3% | 4,141 | +4.9% | 0.00% | – |
Q4 2023 | $290,291 | -46.2% | 3,949 | -11.7% | 0.00% | – |
Q1 2022 | $540,000 | -27.1% | 4,473 | -1.7% | 0.00% | – |
Q4 2021 | $741,000 | -9.7% | 4,551 | -21.7% | 0.00% | – |
Q3 2021 | $821,000 | +332.1% | 5,810 | +324.1% | 0.00% | – |
Q2 2021 | $190,000 | -14.0% | 1,370 | -3.8% | 0.00% | – |
Q1 2021 | $221,000 | -36.1% | 1,424 | -55.1% | 0.00% | – |
Q4 2020 | $346,000 | +95.5% | 3,171 | +81.0% | 0.00% | – |
Q3 2020 | $177,000 | -28.3% | 1,752 | -20.4% | 0.00% | – |
Q2 2020 | $247,000 | +782.1% | 2,202 | +473.4% | 0.00% | – |
Q1 2020 | $28,000 | -93.7% | 384 | -91.0% | 0.00% | – |
Q4 2019 | $444,000 | +100.9% | 4,254 | +91.8% | 0.00% | – |
Q3 2019 | $221,000 | -19.3% | 2,218 | -7.5% | 0.00% | – |
Q2 2019 | $274,000 | +115.7% | 2,398 | +137.9% | 0.00% | – |
Q1 2019 | $127,000 | -90.6% | 1,008 | -89.9% | 0.00% | -100.0% |
Q4 2018 | $1,357,000 | -48.9% | 10,002 | +3.4% | 0.00% | -50.0% |
Q3 2018 | $2,655,000 | +37.1% | 9,672 | +3.5% | 0.00% | 0.0% |
Q2 2018 | $1,937,000 | +20.6% | 9,348 | -3.9% | 0.00% | +100.0% |
Q1 2018 | $1,606,000 | +18.2% | 9,725 | -2.0% | 0.00% | 0.0% |
Q4 2017 | $1,359,000 | +1219.4% | 9,922 | +1202.1% | 0.00% | – |
Q3 2017 | $103,000 | -92.2% | 762 | -93.0% | 0.00% | -100.0% |
Q2 2017 | $1,319,000 | -74.5% | 10,868 | -77.7% | 0.00% | -60.0% |
Q1 2017 | $5,163,000 | +120.5% | 48,782 | +117.5% | 0.01% | +150.0% |
Q4 2016 | $2,342,000 | -77.1% | 22,432 | -77.6% | 0.00% | -81.8% |
Q3 2016 | $10,237,000 | +3301.0% | 100,314 | +3871.3% | 0.01% | – |
Q2 2016 | $301,000 | -57.4% | 2,526 | -61.8% | 0.00% | -100.0% |
Q1 2016 | $707,000 | +2.2% | 6,605 | +3.5% | 0.00% | 0.0% |
Q4 2015 | $692,000 | +31.8% | 6,384 | +4.1% | 0.00% | 0.0% |
Q3 2015 | $525,000 | -21.4% | 6,133 | -7.4% | 0.00% | 0.0% |
Q2 2015 | $668,000 | +98.8% | 6,625 | +52.3% | 0.00% | – |
Q1 2015 | $336,000 | +36.0% | 4,351 | -6.3% | 0.00% | – |
Q4 2014 | $247,000 | +0.4% | 4,646 | -11.4% | 0.00% | – |
Q3 2014 | $246,000 | +173.3% | 5,246 | +260.5% | 0.00% | – |
Q2 2014 | $90,000 | +34.3% | 1,455 | +44.8% | 0.00% | – |
Q1 2014 | $67,000 | +346.7% | 1,005 | +258.9% | 0.00% | – |
Q4 2013 | $15,000 | -75.0% | 280 | -79.8% | 0.00% | – |
Q3 2013 | $60,000 | +15.4% | 1,383 | 0.0% | 0.00% | – |
Q2 2013 | $52,000 | – | 1,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |